Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
21:45:45 EDT Thu 17 Jul 2025
Enter Symbol
or Name
USA
CA



Forgot password?
Trouble logging in?
Login ID:
Password:
Save

T:MDP - MEDEXUS PHARMACEUTICALS INC. J - https://www.medexus.ca/
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
MDP - T  0.32.87·2.920.12.88+0.062.164.01682232.85  2.92  2.825.56  1.7115:58:51Jun 2515 min RT 2¢
TSX - T0.32.87·2.920.12.88+0.062.137.1951502.85  2.92  2.835.56  1.7115:58:5115 min
NEO ATS - U 2.89+0.072.50.7252.90  2.90  2.8515:14:4815 min
Alpha - A 2.88+0.062.111.33262.89  2.89  2.8215:04:5915 min
Pure - P 2.90+0.082.81.7562.87  2.91  2.8715:41:3915 min
Chi-X - X 2.885+0.0652.32.1662.89  2.90  2.8315:57:2015 min
CX2 - H 2.88+0.062.15.415132.91  2.91  2.8415:58:5115 min
CXD - D 2.88+0.062.11.84172.89  2.90  2.8515:57:2015 min
TriAct - M 2.821.0214    Sep 11-2015 min
Lynx - Y 2.89+0.072.52.9862.90  2.90  2.8415:14:4815 min

Recent Trades - Last 10 of 223
Time ETExPriceChangeVolumeBuyerSellerMarkers
15:58:51H2.880.0610053 Morgan Stanley1 AnonymousK
15:58:51T2.880.0610053 Morgan Stanley1 AnonymousK
15:58:51T2.880.0610053 Morgan Stanley1 AnonymousK
15:58:43T2.880.0610053 Morgan Stanley1 AnonymousK
15:57:39T2.880.0610019 Desjardins1 AnonymousK
15:57:39T2.880.0630019 Desjardins1 AnonymousK
15:57:39T2.880.0610019 Desjardins1 AnonymousK
15:57:39T2.880.0640019 Desjardins1 AnonymousK
15:57:39T2.880.0610019 Desjardins1 AnonymousK
15:57:20D2.880.061001 Anonymous1 AnonymousK

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolPriceTypeHeadline
2025-06-25 18:40C:MDP3.35SEDAR Annual Information FormSEDAR Annual Information Form
2025-06-25 18:40C:MDP3.35SEDAR MD & ASEDAR MD & A
2025-06-25 18:29C:MDP3.35SEDAR Audited Annual Financial StatementsSEDAR Audited Annual Financial Statements
2025-06-25 18:16C:MDP3.35News ReleaseMedexus Announces Strong Fiscal Year 2025 Results, Including Initial Results from Launch of GRAFAPEX (treosulfan) for Injection in the United States
2025-06-17 20:20C:MDP3.03News ReleaseMedexus to file fiscal 2025 results June 25
2025-04-17 16:34C:MDP2.55News ReleaseMedexus completes listing agreement for Trecondyv
2025-04-07 16:19C:MDP2.17News ReleaseMedexus talks up market response to Grafapex
2025-03-14 14:15C:MDP2.57News ReleaseMedexus completes cancellation of Gleolan U.S. licence
2025-02-24 16:32C:MDP2.98News ReleaseMedexus's Grafapex for injection available in U.S.
2025-02-07 05:42C:MDP3.21In the NewsGlobe says Medexus Pharmaceuticals lowered to "hold"
2025-02-06 10:51C:MDP3.79News ReleaseCanadian Investment Regulatory Organization Trade Resumption - MDP
2025-02-06 10:45C:MDP3.79News ReleaseCanadian Investment Regulatory Organization Trading Halt - MDP
2025-02-06 10:35C:MDP3.79Resume TradingMedexus Pharmaceuticals to resume at 7:36 a.m. PT
2025-02-06 10:34C:MDP3.79Halt TradingMedexus Pharmaceuticals halted at 7:31 a.m. PT
2025-02-05 17:39C:MDP3.79SEDAR Interim MD & ASEDAR Interim MD & A
2025-02-05 17:38C:MDP3.79SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2025-02-05 17:31C:MDP3.79News ReleaseMedexus Announces Strong Fiscal Q3 2025 Results, Well-Positioned to Launch GRAFAPEX (treosulfan) for Injection in the United States
2025-02-04 17:54C:MDP3.87News ReleaseMedexus completes listing agreements with Ontario
2025-01-31 18:21C:MDP3.85News ReleaseMedexus to release fiscal Q3 results Feb. 5
2025-01-31 16:44C:MDP3.85News ReleaseMedexus Pharmaceuticals closes $30-million offering